Company NeuPath Health Inc.

Equities

NPTH

CA64133P1009

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Healthcare Facilities & Services

Market Closed - Toronto S.E. Other stock markets 07:44:29 13/05/2024 pm IST			5-day change	1st Jan Change
0.17 ^CAD	0.00%		0.00%	-8.11%

15/03	NeuPath Health Narrows Q4 Loss, Revenue Rises	MT
15/03	NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses.

Number of employees: 156

Managers	Title	Age	Since
Joseph Walewicz CEO	Chief Executive Officer	55	25/20/25
Danish Baig DFI	Director of Finance/CFO	-	01/23/01
Jeff Zygouras DFI	Director of Finance/CFO	-	01/19/01
Peter Blecher CTO	Chief Tech/Sci/R&D Officer	-	-
Bjorn Thies HRO	Human Resources Officer	-	-

Members of the board	Title	Age	Since
Joseph Walewicz CEO	Chief Executive Officer	55	25/20/25
Daniel Chicoine CHM	Chairman	70	25/20/25
Sasha Cucuz BRD	Director/Board Member	46	25/20/25
Jolyon Burton BRD	Director/Board Member	48	10/17/10
Daniel Legault BRD	Director/Board Member	66	17/19/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	56,293,000	55,719,477 ( 98.98 %)	0	98.98 %

Name	Equities	%	Valuation
Bloom Burton Investment Group, Inc. 13.33 %	7,501,500	13.33 %	922 685 $
Claret Asset Management Corp. 10.74 %	6,045,329	10.74 %	743 575 $
Jolyon Burton 8.398 %	4,725,333	8.398 %	581 216 $
Joseph Walewicz 0.6677 %	375,694	0.6677 %	46 210 $
Daniel Legault 0.1602 %	90,139	0.1602 %	11 087 $
Daniel Chicoine 0.1162 %	65,361	0.1162 %	8 039 $
Jeff Zygouras 0.0718 %	40,425	0.0718 %	4 972 $
Sasha Cucuz 0.0358 %	20,139	0.0358 %	2 477 $

NeuPath Health, Inc.

6400 Millcreek Drive Unit 9

L5N 3E7, Mississauga

http://www.neupath.com

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.17 CAD

Average target price

0.5 CAD

Spread / Average Target

+194.12%

Consensus

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEUPATH HEALTH INC.	-8.11%	70.35L
HCA HEALTHCARE, INC.	+20.79%	8.56TCr
CVS HEALTH CORPORATION	-28.75%	7.06TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.68%	2.7TCr
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.19%	1.8TCr
FRESENIUS SE & CO. KGAA	+2.14%	1.76TCr
QUEST DIAGNOSTICS INCORPORATED	+2.10%	1.56TCr
REDE D'OR SÃO LUIZ S.A.	+7.06%	1.35TCr
FRESENIUS MEDICAL CARE AG	+10.43%	1.34TCr
NATERA, INC.	+71.31%	1.32TCr

Other Healthcare Facilities & Services